Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
The office coordinates nationwide testing of new treatment approaches for cancer.
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
Cancer HealthCast: This Unique Network Closes Research Gaps in Cancer Genomics
Dr. Leah Mechanic, Program Director at NCI and Dr. Bettina Drake, Professor at Washington University School of Medicine
24m listen -
HealthCast: Indian Health Service's Modernization Journey Means Replacing HHS’s Oldest Legacy System
Indian Health Service CIO Mitchell Thornbrugh joins HealthCast to talk about ways that IHS is progressing in its modernization program and the need for a patient-centered, human-centered approach to care.
26m listen -
CyberCast: CISA Task Force Prioritizes Managing Critical Infrastructure Risks, Countering Future Threats
The National Risk Management Center creates a unique task force designed to mitigate supply chain vulnerabilities, identify emerging threats and boost resiliency.
26m listen -
DOD Tackles Talent Management for the AI Age
Angela Cough, Chief of Digital Talent Management Office, DOD CDAO
28m listen